Dysregulation of the MYCN gene correlates with the development of various other cancer types, such as breast cancer, small-cell lung cancer, prostate cancer, basal cell carcinoma, acute lymphoblastic leukemia, and glioblastoma.21 This evidence concerns the gene MYCN and cancer.